Earnings release

Eli Lilly and Company Eli Lilly and Company · 2026 Q2

ReportedAug 5, 2026
Period endedJun 30, 2026
Rule of 40+81

Consensus vs reported

EPS · ADJUSTED BEAT +28%
$8.38
vs $6.55 expected
QoQ
YoY
Revenue BEAT +11%
$22.97B
vs $20.69B expected
QoQ+16.0%
YoY+47.7%

QoQ and YoY are measured on the same basis as each panel's own consensus, so no panel compares two different measures.

2026 Q2 preview

Reported this quarter

Each tile opens the full quarterly series. Download the numbers as CSV or JSON.

What we learned

  1. The analyst panel was modelling a charge, not the business. Consensus had fallen 25.7% in thirty days to $6.55; adjusted EPS came in at $8.38 , beating it by 27.9% — almost precisely reversing the cut.
  2. The $3.80 consensus range was about an accounting line. Adjusted EPS landed near the top of the $5.28–9.08 span while GAAP EPS was $7.94 , $0.44 below it. The business number and the accounting number differ by exactly the item the range was arguing about.
  3. Revenue growth is the durable half. +47.6% to $22.97B — the fifth straight quarter above 40%.
  4. The cash line is lumpy capital expenditure, not an unstable engine. Free-cash-flow margins of 1.2%, 8.9%, 38.3%, 3.5%, 15.2% across the tracked quarters describe capex landing in lumps.
  5. A Rule of 40 that swings 46 points across four quarters of the same business is measuring the capex calendar. 63.80 trailing against a per-quarter range of 46 to 92, which is why the preview quoted it both ways.

Read the full analysis: Lilly's $3.80 Consensus Range Was a Disagreement About One Line. The Business Printed $8.38. →

Coverage around this release

Estimate against reported

$9.48$4.73-$0.032024 Q3 reported $1.072024 Q32024 Q4 reported $4.882024 Q42025 Q1 reported $3.062025 Q12025 Q2 reported $6.292025 Q22025 Q3 reported $6.212025 Q32025 Q4 reported $7.392025 Q42026 Q1 reported $8.262026 Q12026 Q2 estimate $6.552026 Q2 reported $8.382026 Q2
Our published estimate Reported EPS
QuarterEstimateReportedSurprise
2024 Q3 $1.07
2024 Q4 $4.88
2025 Q1 $3.06
2025 Q2 $6.29
2025 Q3 $6.21
2025 Q4 $7.39
2026 Q1 $8.26
2026 Q2 $6.55 $8.38 +28%

Estimates are the consensus we published on our own preview for that quarter; quarters we did not preview carry the reported figure only. Where a consensus was set on a non-GAAP basis, the reported column shows that same measure.

Sources & downloads

Company Published by the company on the day of the release.
HTML Earnings press release Investor relations announcement
SEC filings Filed with the SEC under CIK 59478.
JSON Company facts (XBRL) Every figure LLY has reported to the SEC

2026 Q2 across the sector

Every LLY quarter